Particle Dynamics Acquires EUROAPI UK

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing site, with a simultaneous closing to Particle Dynamics—a global leader in particle processing, delivery technologies, and finished dose manufacturing for the nutraceutical, consumer health, and pharmaceutical sectors.

“The divestment of Haverhill is a key step toward optimizing our industrial footprint and advancing our FOCUS-27 transformation plan. This transaction strengthens our efficiency and focus on our strategic network, reinforcing our commitment to execution,” said David Seignolle, CEO of EUROAPI. “We are grateful to our UK colleagues for their contribution, professionalism and dedication over the years and we are committed to supporting them with this transition. We believe that Particle Dynamics, with its strong expertise and growing international presence, is well placed to build on the site’s capabilities and support its continued development.”

“Particle Dynamics’ acquisition of EUROAPI UK Ltd is part of a strategic move to strengthen our global particle engineering capabilities, and expand the market segments we can serve,” said Nicolas Fortin, CEO of Particle Dynamics. “We are committed to invest in the Haverhill site, with plans to add new commercial-scale spray drying capabilities, and exceptional talents, as we extend our high quality CDMO service offerings to pharmaceutical innovators.”

The financial terms of the transaction have not been disclosed.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.